C. Missale et al., NERVE GROWTH-FACTOR DIRECTS DIFFERENTIATION OF THE BIPOTENTIAL CELL-LINE GH-3 INTO THE MAMMOTROPH PHENOTYPE, Endocrinology, 135(1), 1994, pp. 290-298
GH-3 is an established cell line which, for the production of both PRL
and GH, may be related to the bipotential somatomammotroph from which
both somatotroph and mammotroph cells derive. In the present study we
first report that GH-3 cells express both the gpl40trk and the gp75 c
omponents of the nerve growth factor (NGF) receptor and that NGF dicta
tes a nonneuronal type of differentiation of this cell line of ectoder
mal origin. After exposure to NGF, GH-3 cells markedly decreased their
proliferation rate. This effect, which was maximal (50% inhibition) 3
days after beginning the treatment and was maintained during the foll
owing days of exposure, was paralleled by a change in the hormone prod
uction. The secretion of PRL was increased 6-fold, but that of GH was
remarkably inhibited. Moreover, GH-3 cells expressed the mammotroph-sp
ecific D-2 receptor protein in response to NGF, as shown by binding wi
th the D-2 receptor ligand N-(p-aminophenetyl)spiperone coupled to flu
orescein. The present data thus show that NGF induces the differentiat
ion of GH-3 cells into one of their physiological counterparts, the ma
mmotroph cell, and together with the finding that NGF receptors are ex
pressed in the anterior pituitary suggest a physiological role for the
neurotrophic factor in pituitary ontogenesis.